Featured Research

from universities, journals, and other organizations

Chronic pain in dogs with bone cancer relieved with new treatment

Date:
October 23, 2013
Source:
American Society of Anesthesiologists (ASA)
Summary:
A single injection eased severe, chronic pain caused by late-stage bone cancer in dogs, according to a study. Dogs with bone cancer that received a neurotoxin injection had significantly more pain relief than those that got standard care without the injection.

A radiograph of a dog's leg with a cancerous lesion.
Credit: Image courtesy of American Society of Anesthesiologists (ASA)

A single injection eased severe, chronic pain caused by late-stage bone cancer in dogs, according to a study in the November issue of Anesthesiology. Dogs with bone cancer that received a neurotoxin injection had significantly more pain relief than those that got standard care without the injection.

"Dogs are part of the family and we do everything we can to relieve them of pain and discomfort when they are sick," said Dorothy Cimino Brown, D.V.M., School of Veterinary Medicine, University of Pennsylvania, Philadelphia. "In addition to sharing emotional attachments with our dogs, humans share many of the same ailments our pets suffer when fighting cancer. By studying the positive pain relief this treatment afforded dogs, we are hopeful it may also be effective for humans."

The evolution of bone cancer pain in dogs parallels what occurs in humans, with the frequency and intensity of pain increasing over weeks and months. As the cancer advances, both canine and human patients experience life-altering pain, which greatly affects their daily activities and quality of life. The standard treatment for dogs with late-stage bone cancer can include opioids, steroids, and palliative radiation. All of these treatments can have negative side effects.

The owners of 70 dogs enrolled their pets in this study. Half the dogs received an injection of a neurotoxin, called substance P-saporin (SP-sap), as well as standard care. The other half (i.e., the control group) received standard care without the neurotoxin injection. The average age of the dogs was between 8 and 9 years and their average weight was 90 pounds. Multiple breeds participated in the study, including: Rottweilers, Labrador Retrievers, Golden Retrievers and mixed breeds.

Neurotoxins are historically known for the disease they can cause, such as botulism, according to Dr. Brown. More recently, however, scientists have learned to harness properties of neurotoxins for positive uses. For example, Botox is used to eliminate wrinkles and SP-sap is used to decrease pain. The SP portion of the neurotoxin works by attaching to a pain-sensing nerve and then the "sap" part gets inside the pain-sensing nerve and causes it to die.

Within six weeks of beginning the study, 74 percent (26) of the dogs in the control group needed to be "unblinded" (i.e., their status in the study revealed) and their pain relief regimen adjusted compared to 24 percent of the dogs (eight) in the group that received the injection. This was a statistically significant difference.

Other study results included a 6 percent increase in pain severity scores for dogs in the control group, while the dogs in the SP-sap group had no change in pain severity score. In addition, the dogs in the control group had an 8 percent increase in how pain interferes with their typical activities, while the SP-sap dogs had a 5 percent improvement in this pain impact score. Finally, one dog in the control group responded with improved lameness, while 6 dogs in the SP-sap group became less lame. While these secondary study results were not statistically significant because they were only assessed two weeks after injection, they are promising.

"The overriding goal of this research is to identify breakthroughs in managing chronic pain in both people and dogs by taking advantage of the fact that pets, through the course of their natural lives, develop many of the same medical conditions causing chronic pain that develop in people," said Dr. Brown. "Additionally we can 'measure' this pain in companion animals like we do in people, quantifying severity and impact on routine activities, mobility and sleep."

The positive pain relieving effect that SP-sap had was significant, according to the study. It both provides promising data for canine patients suffering from cancer and encourages further research into the use of SP-sap for chronic pain control in humans.


Story Source:

The above story is based on materials provided by American Society of Anesthesiologists (ASA). Note: Materials may be edited for content and length.


Journal Reference:

  1. Brown, Dorothy Cimino; Agnello, Kimberly. Intrathecal Substance P-Saporin in the Dog: Efficacy in Bone Cancer Pain. Anesthesiology, November 2013

Cite This Page:

American Society of Anesthesiologists (ASA). "Chronic pain in dogs with bone cancer relieved with new treatment." ScienceDaily. ScienceDaily, 23 October 2013. <www.sciencedaily.com/releases/2013/10/131023090420.htm>.
American Society of Anesthesiologists (ASA). (2013, October 23). Chronic pain in dogs with bone cancer relieved with new treatment. ScienceDaily. Retrieved September 21, 2014 from www.sciencedaily.com/releases/2013/10/131023090420.htm
American Society of Anesthesiologists (ASA). "Chronic pain in dogs with bone cancer relieved with new treatment." ScienceDaily. www.sciencedaily.com/releases/2013/10/131023090420.htm (accessed September 21, 2014).

Share This



More Plants & Animals News

Sunday, September 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Raw: San Diego Zoo Welcomes Cheetah Cubs

Raw: San Diego Zoo Welcomes Cheetah Cubs

AP (Sep. 20, 2014) The San Diego Zoo has welcomed two Cheetah cubs to its Safari Park. The nearly three-week-old female cubs are being hand fed and are receiving around the clock care. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Chocolate Museum Opens in Brussels

Chocolate Museum Opens in Brussels

AFP (Sep. 19, 2014) Considered a "national heritage" in Belgium, chocolate now has a new museum in Brussels. In a former chocolate factory, visitors to the permanent exhibition spaces, workshops and tastings can discover derivatives of the cocoa bean. Duration: 01:00 Video provided by AFP
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins